Colchicine allows prolonged survival of highly reactive renal allograft in the rat

Daniel Ostermann, Norberto Perico, Ornella Imberti, Corrado Barbui, Mario Bontempelli, Giuseppe Remuzzi

Research output: Contribution to journalArticle

Abstract

Colchicine, with its immunosuppressive properties, has been used with beneficial effects in autoimmune diseases. Whether colchicine, by virtue of the above properties, could attenuate the process of kidney allograft rejection in the rat is investigated in this report. Untreated Lewis rats (N = 6) given an incompatible kidney allograft from Brown-Norway rats rejected the graft within 12 days. Colchicine at a daily ip dose of 40 (N = 6) or 10 (N= 4) μg/kg promoted long-term survival (>170 days) of major histocompatibility complex-incompatible kidney grafts. Animals (N = 4) given 4 μg of colchicine per kilogram had a graft failure within 10 days. Experiments have also been performed to evaluate the effect of colchicine withdrawal at different time intervals from transplantation on subsequent allograft survival. Colchicine (40 μg/kg per day ip) was given for 12, 6, or 1 mo or for 15 days to an additional four groups of six animals each without any other immunosuppressants. The withdrawal of colchicine did confer long-term inhibition of the immune system in animals treated for at least 1 mo, as documented by a graft survival of more than 80 days. By contrast, those animals who discontinued colchicine after only 15 days of treatment had graft rejection within the next 8 days. Mixed lymphocyte culture experiments showed a significant (P <0.01) reduction of the proliferation of peripheral blood lymphocytes taken from all groups of animals 30 days after colchicine withdrawal when challenged with Brown-Norway lymphocytes. These findings confirm the immunomodulatory effect of colchicine observed in previous studies and show for the first time that such a property could be used to prevent allograft rejection, at least in the rat.

Original languageEnglish
Pages (from-to)1294-1299
Number of pages6
JournalJournal of the American Society of Nephrology
Volume4
Issue number6
Publication statusPublished - Dec 1993

Fingerprint

Colchicine
Allografts
Kidney
Lymphocytes
Immunosuppressive Agents
Transplants
Graft Rejection
Graft Survival
Norway
Major Histocompatibility Complex
Autoimmune Diseases
Immune System
Transplantation

Keywords

  • Graft rejection
  • Immunosuppression
  • Unresponsiveness

ASJC Scopus subject areas

  • Nephrology

Cite this

Colchicine allows prolonged survival of highly reactive renal allograft in the rat. / Ostermann, Daniel; Perico, Norberto; Imberti, Ornella; Barbui, Corrado; Bontempelli, Mario; Remuzzi, Giuseppe.

In: Journal of the American Society of Nephrology, Vol. 4, No. 6, 12.1993, p. 1294-1299.

Research output: Contribution to journalArticle

Ostermann, Daniel ; Perico, Norberto ; Imberti, Ornella ; Barbui, Corrado ; Bontempelli, Mario ; Remuzzi, Giuseppe. / Colchicine allows prolonged survival of highly reactive renal allograft in the rat. In: Journal of the American Society of Nephrology. 1993 ; Vol. 4, No. 6. pp. 1294-1299.
@article{53b63b508577471588f77eb4b86c042f,
title = "Colchicine allows prolonged survival of highly reactive renal allograft in the rat",
abstract = "Colchicine, with its immunosuppressive properties, has been used with beneficial effects in autoimmune diseases. Whether colchicine, by virtue of the above properties, could attenuate the process of kidney allograft rejection in the rat is investigated in this report. Untreated Lewis rats (N = 6) given an incompatible kidney allograft from Brown-Norway rats rejected the graft within 12 days. Colchicine at a daily ip dose of 40 (N = 6) or 10 (N= 4) μg/kg promoted long-term survival (>170 days) of major histocompatibility complex-incompatible kidney grafts. Animals (N = 4) given 4 μg of colchicine per kilogram had a graft failure within 10 days. Experiments have also been performed to evaluate the effect of colchicine withdrawal at different time intervals from transplantation on subsequent allograft survival. Colchicine (40 μg/kg per day ip) was given for 12, 6, or 1 mo or for 15 days to an additional four groups of six animals each without any other immunosuppressants. The withdrawal of colchicine did confer long-term inhibition of the immune system in animals treated for at least 1 mo, as documented by a graft survival of more than 80 days. By contrast, those animals who discontinued colchicine after only 15 days of treatment had graft rejection within the next 8 days. Mixed lymphocyte culture experiments showed a significant (P <0.01) reduction of the proliferation of peripheral blood lymphocytes taken from all groups of animals 30 days after colchicine withdrawal when challenged with Brown-Norway lymphocytes. These findings confirm the immunomodulatory effect of colchicine observed in previous studies and show for the first time that such a property could be used to prevent allograft rejection, at least in the rat.",
keywords = "Graft rejection, Immunosuppression, Unresponsiveness",
author = "Daniel Ostermann and Norberto Perico and Ornella Imberti and Corrado Barbui and Mario Bontempelli and Giuseppe Remuzzi",
year = "1993",
month = "12",
language = "English",
volume = "4",
pages = "1294--1299",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "6",

}

TY - JOUR

T1 - Colchicine allows prolonged survival of highly reactive renal allograft in the rat

AU - Ostermann, Daniel

AU - Perico, Norberto

AU - Imberti, Ornella

AU - Barbui, Corrado

AU - Bontempelli, Mario

AU - Remuzzi, Giuseppe

PY - 1993/12

Y1 - 1993/12

N2 - Colchicine, with its immunosuppressive properties, has been used with beneficial effects in autoimmune diseases. Whether colchicine, by virtue of the above properties, could attenuate the process of kidney allograft rejection in the rat is investigated in this report. Untreated Lewis rats (N = 6) given an incompatible kidney allograft from Brown-Norway rats rejected the graft within 12 days. Colchicine at a daily ip dose of 40 (N = 6) or 10 (N= 4) μg/kg promoted long-term survival (>170 days) of major histocompatibility complex-incompatible kidney grafts. Animals (N = 4) given 4 μg of colchicine per kilogram had a graft failure within 10 days. Experiments have also been performed to evaluate the effect of colchicine withdrawal at different time intervals from transplantation on subsequent allograft survival. Colchicine (40 μg/kg per day ip) was given for 12, 6, or 1 mo or for 15 days to an additional four groups of six animals each without any other immunosuppressants. The withdrawal of colchicine did confer long-term inhibition of the immune system in animals treated for at least 1 mo, as documented by a graft survival of more than 80 days. By contrast, those animals who discontinued colchicine after only 15 days of treatment had graft rejection within the next 8 days. Mixed lymphocyte culture experiments showed a significant (P <0.01) reduction of the proliferation of peripheral blood lymphocytes taken from all groups of animals 30 days after colchicine withdrawal when challenged with Brown-Norway lymphocytes. These findings confirm the immunomodulatory effect of colchicine observed in previous studies and show for the first time that such a property could be used to prevent allograft rejection, at least in the rat.

AB - Colchicine, with its immunosuppressive properties, has been used with beneficial effects in autoimmune diseases. Whether colchicine, by virtue of the above properties, could attenuate the process of kidney allograft rejection in the rat is investigated in this report. Untreated Lewis rats (N = 6) given an incompatible kidney allograft from Brown-Norway rats rejected the graft within 12 days. Colchicine at a daily ip dose of 40 (N = 6) or 10 (N= 4) μg/kg promoted long-term survival (>170 days) of major histocompatibility complex-incompatible kidney grafts. Animals (N = 4) given 4 μg of colchicine per kilogram had a graft failure within 10 days. Experiments have also been performed to evaluate the effect of colchicine withdrawal at different time intervals from transplantation on subsequent allograft survival. Colchicine (40 μg/kg per day ip) was given for 12, 6, or 1 mo or for 15 days to an additional four groups of six animals each without any other immunosuppressants. The withdrawal of colchicine did confer long-term inhibition of the immune system in animals treated for at least 1 mo, as documented by a graft survival of more than 80 days. By contrast, those animals who discontinued colchicine after only 15 days of treatment had graft rejection within the next 8 days. Mixed lymphocyte culture experiments showed a significant (P <0.01) reduction of the proliferation of peripheral blood lymphocytes taken from all groups of animals 30 days after colchicine withdrawal when challenged with Brown-Norway lymphocytes. These findings confirm the immunomodulatory effect of colchicine observed in previous studies and show for the first time that such a property could be used to prevent allograft rejection, at least in the rat.

KW - Graft rejection

KW - Immunosuppression

KW - Unresponsiveness

UR - http://www.scopus.com/inward/record.url?scp=0027767835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027767835&partnerID=8YFLogxK

M3 - Article

C2 - 8130355

AN - SCOPUS:0027767835

VL - 4

SP - 1294

EP - 1299

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 6

ER -